In Black South Africans from Rural and Urban Communities, the 4G/5G PAI-1 Polymorphism Influences PAI-1 Activity, but Not Plasma Clot Lysis Time

被引:6
|
作者
de Lange, Zelda [1 ]
Rijken, Dingeman C. [2 ]
Hoekstra, Tiny [1 ,3 ]
Conradie, Karin R. [1 ]
Jerling, Johann C. [1 ]
Pieters, Marlien [1 ]
机构
[1] North West Univ, Ctr Excellence Nutr, Potchefstroom, South Africa
[2] Erasmus Univ, Med Ctr, Dept Haematol, Rotterdam, Netherlands
[3] Leiden Univ, Med Ctr, Dept Clin Epidemiol, Leiden, Netherlands
来源
PLOS ONE | 2013年 / 8卷 / 12期
基金
英国医学研究理事会; 新加坡国家研究基金会;
关键词
PLASMINOGEN-ACTIVATOR INHIBITOR-1; MYOCARDIAL-INFARCTION; INSULIN-RESISTANCE; VENOUS THROMBOSIS; INCOME COUNTRIES; CORONARY ATHEROSCLEROSIS; CARDIOVASCULAR-DISEASE; CIRCULATING LEVELS; METABOLIC SYNDROME; ADIPOSE-TISSUE;
D O I
10.1371/journal.pone.0083151
中图分类号
O [数理科学和化学]; P [天文学、地球科学]; Q [生物科学]; N [自然科学总论];
学科分类号
07 ; 0710 ; 09 ;
摘要
Data on genetic and environmental factors influencing PAI-1 levels and their consequent effect on clot lysis in black African populations are limited. We identified polymorphisms in the promoter area of the PAI-1 gene and determined their influence on PAI-1(act) levels and plasma clot lysis time (CLT). We also describe gene-environment interactions and the effect of urbanisation. Data from 2010 apparently healthy urban and rural black participants from the South African arm of the PURE study were cross-sectionally analysed. The 5G allele frequency of the 4G/5G polymorphism was 0.85. PAI-1(act) increased across genotypes in the urban subgroup (p = 0.009) but not significantly in the rural subgroup, while CLT did not differ across genotypes. Significant interaction terms were found between the 4G/5G polymorphism and BMI, waist circumference and triglycerides in determining PAI-1(act), and between the 4G/5G polymorphism and fibrinogen and fibrinogen gamma prime in determining CLT. The C428T and G429A polymorphisms did not show direct relationships with PAI-1(act) or CLT but they did influence the association of other environmental factors with PAI-1(act) and CLT. Several of these interactions differed significantly between rural and urban subgroups, particularly in individuals harbouring the mutant alleles. In conclusion, although the 4G/5G polymorphism significantly affected PAI-1(act), it contributed less than 1% to the PAI-1(act) variance. (Central) obesity was the biggest contributor to PAI-1(act) variance (12.5%). Urbanisation significantly influenced the effect of the 4G/5G polymorphism on PAI-1(act) as well as gene-environment interactions for the C428T and G429A genotypes in determining PAI-1(act) and CLT.
引用
收藏
页数:8
相关论文
共 50 条
  • [1] PAI-1 level and the PAI-1 4G/5G polymorphism in relation to risk of non-fatal myocardial infarction
    Leander, K
    Wiman, B
    Hallqvist, J
    Sten-Linder, M
    de Faire, U
    THROMBOSIS AND HAEMOSTASIS, 2003, 89 (06) : 1064 - 1071
  • [2] The influence of metabolic syndrome components on plasma PAI-1 concentrations is modified by the PAI-1 4G/5G genotype and ethnicity
    Naran, Nitien Hira
    Chetty, Nanthakumarn
    Crowther, Nigel John
    ATHEROSCLEROSIS, 2008, 196 (01) : 155 - 163
  • [3] The impact of the PAI-1 4G/5G polymorphism on the outcome of patients with ALI/ARDS
    Tsangaris, Iraklis
    Tsantes, Argiris
    Bonovas, Stefanos
    Lignos, Michalis
    Kopterides, Petros
    Gialeraki, Argiro
    Rapti, Evdoxia
    Orfanos, Stylianos
    Dimopoulou, Ioanna
    Travlou, Anthi
    Armaganidis, Apostolos
    THROMBOSIS RESEARCH, 2009, 123 (06) : 832 - 836
  • [4] PAI-1 4G/5G Polymorphism and Plasma Levels Association in Patients with Coronary Artery Disease
    Lima, Luciana Moreira
    Carvalho, Maria das Gracas
    Fonseca Neto, Cirilo Pereira
    Faria Garcia, Jose Carlos
    Sousa, Marinez Oliveira
    ARQUIVOS BRASILEIROS DE CARDIOLOGIA, 2011, 97 (06) : 462 - 467
  • [5] The plasminogen activator inhibitor-1 (PAI-1) gene-844 A/G and-675 4G/5G promoter polymorphism significantly influences plasma PAI-1 levels in women with polycystic ovary syndrome
    Sun Lin
    Zhang Huiya
    Liu Bo
    Wei Wei
    Guan Yongmei
    ENDOCRINE, 2009, 36 (03) : 503 - 509
  • [6] The Association of Plasminogen Activator Inhibitor Type 1 (PAI-1) Level and PAI-1 4G/5G Gene Polymorphism with the Formation and the Grade of Endometrial Cancer
    Yildirim, Malik Ejder
    Karakus, Savas
    Kurtulgan, Hande Kucuk
    Kilicgun, Hasan
    Ersan, Serpil
    Bakir, Sevtap
    BIOCHEMICAL GENETICS, 2017, 55 (04) : 314 - 321
  • [7] 4G/5G PAI-1 promoter polymorphism and acute-phase levels of PAI-1 following coronary bypass surgery: A prospective study
    Burzotta, F
    Iacoviello, L
    Di Castelnuovo, A
    Zamparelli, R
    D'Orazio, A
    Amore, C
    Schiavello, R
    Donati, MB
    Maseri, A
    Possati, G
    Andreotti, F
    JOURNAL OF THROMBOSIS AND THROMBOLYSIS, 2003, 16 (03) : 149 - 154
  • [8] Clinical impact of the PAI-1 4G/5G polymorphism in Chinese patients with venous thromboembolism
    Wang, Ziran
    Kong, Lingjun
    Luo, Guoju
    Zhang, Han
    Sun, Fengchun
    Liang, Wenjuan
    Wu, Wei
    Guo, Zijian
    Zhang, Rui
    Dou, Yaling
    THROMBOSIS JOURNAL, 2022, 20 (01)
  • [9] Role of the 4G/5G polymorphism of PAI-1 gene promoter on PAI-1 levels in obese patients - Influence of fat distribution and insulin-resistance
    Sartori, MT
    Vettor, R
    De Pergola, G
    De Mitrio, V
    Saggiorato, G
    Della Mea, P
    Patrassi, GM
    Lombardi, AM
    Fabris, R
    Girolami, A
    THROMBOSIS AND HAEMOSTASIS, 2001, 86 (05) : 1161 - 1169
  • [10] PAI-1 4G/5G polymorphism and coronary artery disease risk: a meta-analysis
    Liang, Zhongshu
    Jiang, Weihong
    Ouyang, Mao
    Yang, Kan
    INTERNATIONAL JOURNAL OF CLINICAL AND EXPERIMENTAL MEDICINE, 2015, 8 (02): : 2097 - 2107